We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




High Fetal Estrogen Levels Linked to Autism

By LabMedica International staff writers
Posted on 13 Aug 2019
Print article
Image: The Xevo TQ-S micro Triple Quadrupole Mass Spectrometry (Photo courtesy of Waters).
Image: The Xevo TQ-S micro Triple Quadrupole Mass Spectrometry (Photo courtesy of Waters).
The male-biased prevalence of autism, together with the finding that autistic girls have a higher mutational load than autistic boys, suggests that males have a higher likelihood of developing autism.

Although autism is strongly heritable and sex-associated genetic mechanisms could contribute to this implication of sexual differentiation in autism, prenatal hormone exposure and a brief surge in fetal testosterone are critical for sexual differentiation and masculinization in humans.

An international team of scientists led by those at the University of Cambridge (Cambridge, UK) testing the amniotic fluid samples from the same 98 individuals sampled from the Danish Biobank, which has collected amniotic samples from over 100,000 pregnancies. The team concentrated at investigating prenatal sex steroid hormones called estrogens. This is an important next step because some of the hormones previously studied are directly converted into estrogens.

The amniotic fluid samples were assayed for estradiol, estriol, estrone, and estrone sulphate, using liquid chromatography-tandem mass spectroscopy. The LC-MS/MS setup consisted of an Acquity Ultra Performance Liquid Chromatography machine with an Acquity sample manager and an Acquity sample organizer, followed by Xevo TQ-S triple quadrupole mass spectrometer equipped with an electron spray ionization probe.

The scientists reported that all four estrogens were significantly elevated, on average, in the 98 fetuses that later developed autism, compared to the 177 fetuses who did not. High levels of prenatal estrogens were even more predictive of likelihood of autism than were high levels of prenatal androgens, such as testosterone. Contrary to popular belief that associates estrogens with feminization, prenatal estrogens have effects on brain growth and also masculinize the brain in many mammals.

The authors concluded that they had demonstrated that prenatal estradiol, estriol and estrone are elevated in boys who went on to develop autism. High levels of prenatal estradiol contribute to a greater degree to autism likelihood than other prenatal sex steroids, including testosterone. Prenatal estrogenic excess is a characteristic of autism and may interact with genetic predisposition to affect neurodevelopment. The study was published on July 29, 2019, in the journal Molecular Psychiatry.

Related Links:
University of Cambridge

New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Benchtop Cooler
PCR-Cooler & PCR-Rack
New
Silver Member
Fixed Speed Tube Rocker
GTR-FS

Print article

Channels

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.